MOLECULIN BIOTECH INC (MBRX:NASDAQ)
$2.62 0.07 (2.7451%)
Analysed MOLECULIN BIOTECH INC (MBRX:NASDAQ) News Sources
Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile
07-04-2026
yahoo.com
Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
23-03-2026
yahoo.com
Moleculin Reports Full Year 2025 Financial Results and Confirms Highly Anticipated 45-Patient Interim Data Unblinding in Pivotal MIRACLE Trial On Track for Mid-2026
19-03-2026
yahoo.com
Moleculin to Present at 38th Annual ROTH Conference
17-03-2026
yahoo.com
Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study
11-03-2026
yahoo.com
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
19-02-2026
yahoo.com
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
18-02-2026
yahoo.com
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
17-02-2026
yahoo.com
Moleculin Launches CEO Corner Platform to Share Strategic Insights
13-02-2026
yahoo.com
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026
09-02-2026
yahoo.com
What is the current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ)?
The current price of MOLECULIN BIOTECH INC (MBRX:NASDAQ) is $2.62.
MOLECULIN BIOTECH INC (MBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is $0.07.
MOLECULIN BIOTECH INC (MBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MOLECULIN BIOTECH INC (MBRX:NASDAQ) since the previous trading day is 2.7451%.
What is the most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?
The most recent average sentiment score for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ)?
The most recent sentiment for MOLECULIN BIOTECH INC (MBRX:NASDAQ) is .
SEC-8K** Filing Available For MOLECULIN BIOTECH INC (MBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.